Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
- 2019-03
- Meta-Analysis · n = 1,045
- Journal of ethnopharmacology 231
- Emanuel L Peter
- Félicien Mushagalusa Kasali
- Serawit Deyno
- Andrew Mtewa
- Prakash B Nagendrappa
- Casim Umba Tolo
- Patrick Engeu Ogwang
- Duncan Sesaazi
- PubMed: 30385422
- DOI: 10.1016/j.jep.2018.10.033
- High evidence
- Clinical
M. charantia also lowered FPG in prediabetes (mean difference -0.31 mmol/L, n=52); the evidence was downgraded to low quality because the study had unclear risk of bias and inadequate sample size.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No